Detalhe da pesquisa
1.
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.
Haematologica
; 108(4): 1105-1114, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770529
2.
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT.
Biol Blood Marrow Transplant
; 26(9): 1559-1566, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417491
3.
Evolution or revolution in multiple myeloma therapy and the role of the UK.
Br J Haematol
; 191(4): 542-551, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190259
4.
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 24(5): 930-936, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29339268
5.
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Haematologica
; 103(3): 514-521, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217776
6.
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances.
Biol Blood Marrow Transplant
; 23(7): 1193-1202, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285082
7.
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Haematologica
; 102(1): 160-167, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634201
8.
Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial.
Biol Blood Marrow Transplant
; 22(6): 1009-1016, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827659
9.
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(6): 1054-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25708221
10.
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial.
Br J Haematol
; 170(3): 336-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891006
11.
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.
Blood
; 121(25): 5055-63, 2013 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23482933
12.
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Transfusion
; 54(10): 2514-22, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24964911
13.
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial.
EJHaem
; 4(1): 246-250, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819186
14.
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
J Clin Med
; 11(12)2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743620
15.
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study.
Clin Lymphoma Myeloma Leuk
; 21(10): 686-693, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158265
16.
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.
Br J Haematol
; 148(2): 323-31, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19912215
17.
Primary plasma cell leukemia and autologous stem cell transplantation.
Haematologica
; 95(5): 804-9, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20442444
18.
Efficacy and outcome of autologous transplantation in rare myelomas.
Haematologica
; 95(12): 2126-33, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20971818
19.
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor.
Bone Marrow Transplant
; 55(2): 356-366, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31534192
20.
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling.
Exp Hematol
; 36(11): 1567-71, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18722040